Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
COSMAXBIO is a prominent South Korean contract development and manufacturing organization (CDMO) specializing in health functional foods and nutraceuticals. As a core subsidiary of the COSMAX Group, the company provides comprehensive ODM and OEM services, ranging from raw material sourcing and R&D to final product manufacturing and packaging. Their product portfolio includes a wide array of supplements such as probiotics, vitamins, and beauty-focused inner beauty products, delivered in innovative formats like soft capsules, jellies, and liquids. COSMAXBIO maintains high-standard manufacturing facilities with GMP and NSF certifications, serving both domestic and international health and wellness brands. The company is particularly noted for its pioneering work in soft capsule technology and its continuous investment in functional ingredient research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on COSMAXBIO.